Page last updated: 2024-08-23

tetradecanoylphorbol acetate and Brain Diseases

tetradecanoylphorbol acetate has been researched along with Brain Diseases in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Pan, CF; Xiong, XX; Zheng, YY; Zhu, SM1

Other Studies

1 other study(ies) available for tetradecanoylphorbol acetate and Brain Diseases

ArticleYear
Propofol inhibits aquaporin 4 expression through a protein kinase C-dependent pathway in an astrocyte model of cerebral ischemia/reoxygenation.
    Anesthesia and analgesia, 2009, Volume: 109, Issue:5

    Topics: Animals; Animals, Newborn; Aquaporin 4; Astrocytes; Brain Diseases; Brain Edema; Cell Hypoxia; Cell Survival; Cells, Cultured; Cytoprotection; Dose-Response Relationship, Drug; Down-Regulation; Enzyme Activation; Enzyme Activators; Glucose; L-Lactate Dehydrogenase; Neocortex; Neuroprotective Agents; Oxygen; Propofol; Protein Kinase C; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Signal Transduction; Tetradecanoylphorbol Acetate; Time Factors

2009